Skip to main content
Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc. — Investor Relations & Filings

Ticker · TRVI ISIN · US89532M1018 US Manufacturing
Open in API
Filings indexed 505 across all filing types
Latest filing 2019-02-20 Regulatory Filings
Country US United States of America
Listing US TRVI

About Trevi Therapeutics, Inc.

https://www.trevitherapeutics.com/

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of its investigational therapy, Haduvio™ (oral nalbuphine ER). The company's primary program is aimed at treating chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC). These conditions represent a significant unmet medical need with no approved therapies in the United States. Haduvio is a dual-mechanism therapy that acts as a kappa opioid receptor agonist and a mu opioid receptor antagonist, targeting both central and peripheral nerve pathways believed to cause chronic cough. The company has reported positive results from its Phase 2b CORAL trial in IPF chronic cough and its Phase 2a RIVER trial in refractory chronic cough.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the U.S. Securities and Exchange Commission (SEC) Division of Corporation Finance, responding to comments on an Amendment No. 1 to a Draft Registration Statement on Form S-1. The letter discusses revisions to the Draft Registration Statement, including disclosure changes and legal provisions. It is clearly a regulatory correspondence related to the registration process for securities, specifically a confidential amendment to a Form S-1 registration statement. There is no financial data, earnings information, or report content itself, but rather a response to SEC staff comments and submission of amended draft documents. This type of document fits the category of Regulatory Filings (RNS), which includes compliance documents and correspondence with regulatory bodies that do not constitute the actual report or registration statement itself.
2019-02-20 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for initial public offerings (IPOs) to register securities under the Securities Act of 1933. It includes detailed information about the company, its business, risk factors, management, financial data, and the offering itself. This type of filing is related to capital raising and financing activities. It is not an annual report, earnings release, or any other type of report but specifically a registration statement for a securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or a certification, supporting a high confidence level.
2019-02-20 English
Regulatory Filings 2019
Regulatory Filings
2019-02-15 English
Regulatory Filings 2018
Regulatory Filings Classification · 100% confidence The document is a detailed response letter from a company to the U.S. Securities and Exchange Commission (SEC) regarding comments on a Confidential Draft Registration Statement on Form S-1. The Form S-1 is a registration statement used by companies planning an initial public offering (IPO) to register their securities with the SEC. The content includes detailed responses to SEC comments on disclosures related to clinical trials, risk factors, use of proceeds, management discussion and analysis, and accounting policies. This is not a financial report like an Annual Report or Quarterly Report, nor is it a transcript, presentation, or voting result. It is a regulatory filing related to the registration of securities for an IPO. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes SEC comment letters and responses related to registration statements.
2018-12-21 English
Capital/Financing Update 2018
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for initial public offerings (IPOs) to register securities under the Securities Act of 1933. It includes detailed information about the company, its business, risk factors, management, financial data, and the offering itself. This type of filing is a capital markets document related to fundraising and securities issuance, not a financial report like an annual or quarterly report. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2018-12-21 English
Regulatory Filings 2018
Regulatory Filings
2018-12-18 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.